Correlation Between Entravision Communications and Diamyd Medical
Can any of the company-specific risk be diversified away by investing in both Entravision Communications and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entravision Communications and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entravision Communications and Diamyd Medical AB, you can compare the effects of market volatilities on Entravision Communications and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entravision Communications with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entravision Communications and Diamyd Medical.
Diversification Opportunities for Entravision Communications and Diamyd Medical
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Entravision and Diamyd is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Entravision Communications and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and Entravision Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entravision Communications are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of Entravision Communications i.e., Entravision Communications and Diamyd Medical go up and down completely randomly.
Pair Corralation between Entravision Communications and Diamyd Medical
Assuming the 90 days horizon Entravision Communications is expected to generate 1.08 times more return on investment than Diamyd Medical. However, Entravision Communications is 1.08 times more volatile than Diamyd Medical AB. It trades about 0.12 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about 0.12 per unit of risk. If you would invest 158.00 in Entravision Communications on April 24, 2025 and sell it today you would earn a total of 40.00 from holding Entravision Communications or generate 25.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Entravision Communications vs. Diamyd Medical AB
Performance |
Timeline |
Entravision Communications |
Diamyd Medical AB |
Entravision Communications and Diamyd Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Entravision Communications and Diamyd Medical
The main advantage of trading using opposite Entravision Communications and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entravision Communications position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.Entravision Communications vs. News Corporation | Entravision Communications vs. News Corporation | Entravision Communications vs. Nexstar Media Group | Entravision Communications vs. ITV plc |
Diamyd Medical vs. RYMAN HEALTHCAR | Diamyd Medical vs. CARDINAL HEALTH | Diamyd Medical vs. Phibro Animal Health | Diamyd Medical vs. FEMALE HEALTH |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |